Compugen Ltd: Clinical Trials

2 trials sponsored by Compugen Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1
Phase 22Active not recruiting 1, Completed 1

Follow Compugen Ltd: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
COM701, Normal Saline - Ovarian Cancer, Ovarian Cancer Recurrent
Phase 1 / Phase 2Active not recruitingCompugen Ltd602025-07-212026-10-06
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
COM701 in combination with BMS-986207 and nivolumab. - Endometrial Neoplasms, Ovarian Cancer
Phase 1 / Phase 2CompletedCompugen Ltd482020-08-312024-07-18

Conditions studied

Ovarian Neoplasms (2)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)

Interventions

Nivolumab (1)  ·  Saline Solution (1)

Countries

United States (2)  ·  France (1)  ·  Israel (1)